IgM myeloma: A rare entity characterized by a CD20-CD56 -CD117- immunophenotype and the t(11;14)

British Journal of Haematology

Volumn 140, Issue 5, 2008, Pages 547-551

  Feyler, Sylvia ^a,f   O'Connor, Sheila J M ^a   Rawstron, Andy C ^a   Subash, Chezhian ^a   Ross, Fiona M ^b   Pratt, Guy ^c   Drayson, Mark T ^d   Ashcroft, John ^e   Cook, Gordon ^a   Owen, Roger G ^a  

^a LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^b LRF UK Myeloma Forum Cytogenetic Database   (United Kingdom)

^c BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^e MID YORKSHIRE HOSPITALS NHS TRUST   (United Kingdom)

^f ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Genotype; IgM; Immunophenotype; Myeloma; T(11; 14)

Indexed keywords

CD19 ANTIGEN; CD20 ANTIGEN; CD27 ANTIGEN; CD45 ANTIGEN; CD56 ANTIGEN; CYCLIN D1; IMMUNOGLOBULIN M; STEM CELL FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENOTYPE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MALE; MYELOMA; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ANTIGENS, CD20; ANTIGENS, CD56; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 14; FEMALE; GENOTYPE; HUMANS; IMMUNOGLOBULIN M; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-KIT; RETROSPECTIVE STUDIES; TRANSLOCATION, GENETIC;

EID: 38949087228     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06969.x     Document Type: Article

References (15)

1. Ackroyd, S., O'Connor, S.J., Rawstron, A.C. Owen, R.G. (2005) IgM myeloma with t(4;14)(p16;q32). Cancer Genetics and Cytogenetics, 162, 183 184.
2. Annibali, O., Petrucci, M.T., Del Bianco, P., Gallucci, C., Levi, A., Foa, R. Avvisati, G. (2006) IgM multiple myeloma: report of four cases and review of the literature. Leukemia and Lymphoma, 47, 1565 1569.
3. Avet-Loiseau, H., Garand, R., Lode, L., Harousseau, J.L. Bataille, R. (2003) Translocation t(11;14)(q13;q32) is the hallmark of IgM, IgE, and nonsecretory multiple myeloma variants. Blood, 101, 1570 1571.
4. Chiecchio, L., Protheroe, R.K., Ibrahim, A.H., Cheung, K.L., Rudduck, C., Dagrada, G.P., Cabanas, E.D., Parker, T., Nightingale, M., Wechalekar, A., Orchard, K.H., Harrison, C.J., Cross, N.C., Morgan, G.J. Ross, F.M. (2006) Deletion of chromosome 13 detected by conventional cytogenetics is a critical prognostic factor in myeloma. Leukemia, 20, 1610 1617.
5. De Gramont, A., Grosbois, B., Michaux, J.L., Peny, A.M., Pollet, J.P., Smadja, N., Krulik, M., Debray, J., Bernard, J.F. Monconduit, M. (1990) IgM myeloma: 6 cases and a review of the literature. La Revue de Medicine Interne, 11, 13 18.
6. Dewald, G.W., Therneau, T., Larson, D., Lee, Y.K., Fink, S., Smoley, S., Paternoster, S., Adeyinka, A., Ketterling, R., Van Dyke, D.L., Fonseca, R. Kyle, R. (2005) Relationship of patient survival and chromosome anomalies detected in metaphase and/or interphase cells at diagnosis of myeloma. Blood, 106, 3553 3558.
7. Haghighi, B., Yanagihara, R. Cornbleet, P.J. (1998) IgM myeloma: case report with immunophenotypic profile. American Journal of Hematology, 59, 302 308.
8. Kyle, R.A. Garton, J.P. (1987) The spectrum of IgM monoclonal gammopathy in 430 cases. Mayo Clinic Proceedings, 62, 719 731.
9. O'Connor, S.J.M., Barrans, S.L., Turner, K.R., Dickinson, B.S., Jack, A.S. Owen, R.G. (2007) Routine detection of cytogenetic abnormalities in B-cell lymphoproliferative disorders using interphase FISH techniques. Haematologica, 92 (Suppl. 1 49.
10. Owen, R.G. (2003) Developing diagnostic criteria in Waldenstrom's macroglobulinaemia. Seminars in Oncology, 30, 196 200.
11. Owen, R.G., Parapia, L.A., Higginson, J., Misbah, S.A., Child, J.A., Morgan, G.J. Jack, A.S. (2000) Clinicopathological correlates of IgM paraproteinemias. Clinical Lymphoma, 1, 39 43 (discussion 44-35).
12. Rawstron, A.C., Davies, F.E., DasGupta, R., Ashcroft, A.J., Patmore, R., Drayson, M.T., Owen, R.G., Jack, A.S., Child, J.A. Morgan, G.J. (2002) Flow cytometric disease monitoring in multiple myeloma: the relationship between normal and neoplastic plasma cells predicts outcome after transplantation. Blood, 100, 3095 3100.
13. Rawstron, A.C., Orfao, A., Beksac, M., Bezdíčková, L., Brooimans, R.A., Bumbea, H., Dalva, K., Fuhler, G., Gratama, J., Hose, D., Kovarova, L., Lioznov, M., Mateo, G., Morilla, R., Mylin, A.K., Omede, P., Pellat-Deceunynck, C., Andres, M.P., Petrucci, M., Ruggeri, M., Rymkiewicz, G., Schmitz, A., Schreder, M., Seynaeve, C., Spacek, M., de Tute, R.M., van Valckenborgh, E., Weston-Bell, N., Owen, R.G., San Miguel, J., Sonneveld, P. Johnsen, H.E, on behalf of the European Myeloma Network (2008) Report of the European Myeloma Network (EMN) on multiparametric flow cytometry in multiple myeloma and related disorders. Haematologica, 93, 432 439.
14. Robillard, N., Avet-Loiseau, H., Garand, R., Moreau, P., Pineau, D., Rapp, M.J., Harousseau, J.L. Bataille, R. (2003) CD20 is associated with a small mature plasma cell morphology and t(11;14) in multiple myeloma. Blood, 102, 1070 1071.
15. Schop, R.F., Kuehl, W.M., Van Wier, S.A., Ahmann, G.J., Price-Troska, T., Bailey, R.J., Jalal, S.M., Qi, Y., Kyle, R.A., Greipp, P.R. Fonseca, R. (2002) Waldenstrom macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocations but have frequent 6q deletions. Blood, 100, 2996 3001.